No abstract

Fibrin glue sealant significantly reduced the frequency and severity of intra-abdominal adhesions.

AFLP was used to analyze the genetic diversity among Ochrobactrum strains. AFLP patterns showed a great genomic variability that separated the samples into three distinct clusters. Ochrobactrum intermedium was found to be closely related to Brucella abortus S99.

No abstract

Introducción: El registro de picados por alacrán en el Estado de Guanajuato durante el periodo 2000 – 2005 rebasó en promedio los 24 000 casos por año, con una mortalidad promedio de 3 personas; afectando a núcleos de población, tanto del medio rural como urbano. A muchos años de haberse detectado la problemática, todavía se desconocen con precisión los aspectos epidemiológicos básicos de este fenómeno en el Estado. Material y Métodos: Se realizó un estudio retrospectivo, observacional y descriptivo de los años 2000 a 2005 de los datos recabados por el Sistema Único Automatizado de Vigilancia Epidemiológica de la Secretaría de Salud del Estado de Guanajuato, obteniéndose la tasa de incidencia por municipio y el mapa epidemiológico del Estado. Resultados: Durante el periodo del 2000 al 2005 se reportaron un total de 149 068 picados por alacrán, con una tasa de incidencia de 500,9 por 100 000 hab. ; el principal grupo de edad afectado fue de 15 a 44 años, y los meses con mayor incidencia fueron abril, mayo y junio. Los 15 municipios con mayores tasas de incidencia (de 500,9 a 1991,6 /100 000 hab.) durante este periodo se localizaron en el suroeste y sureste y las zonas de baja incidencia (1,4/100 000 hab.) en el noreste del estado. Conclusiones: Los municipios con tasas de incidencia más altas requieren mayores esfuerzos y acciones tendientes a disminuir la morbilidad en estas áreas, por lo que las medidas de atención primaria deberán estar encaminadas a resolver este gran problema de salud pública.

The 7-day H. pylori eradication regimen with PAC was superior to PCM and PAM. This is probably due to the high resistance rate to metronidazole in the Mexican population. Thus, H. pylori eradication regimens that involve metronidazole cannot be recommended for Mexican patients. RESULTS from this study highlight the regional differences in efficacy of some well established H. pylori eradication regimens, and suggest that culture and susceptibility testing to define H. pylori resistance patterns in specific geographical areas may be indicated before recommending any particular eradication schedule.

More than 500,000 new medical articles are published every year and available time to keep updated is scarcer every day. Nowadays, the task of selecting useful, consistent, and relevant information for clinicians is a priority in many major medical journals. This review has the aim of gathering the results of the most important findings in clinical medicine in the last few years. It is focused on results from randomized clinical trials and well-designed observational research. Findings were included preferentially if they showed solid results, and we avoided as much as possible including only preliminary data, or results that included only non-clinical outcomes.Some of the most relevant findings reported here include the significant benefit of statins in patients with coronary artery disease even with mean cholesterol level. It also provides a substantial review of the most significant trials assessing the effectiveness of IIb/IIIa receptor blockers. In gastroenterology many advances have been made in the H. pylori eradication, and the finding that the cure of H. pylori infection may be followed by gastroesophageal reflux disease. Some new antivirals have shown encouraging results in patients with chronic hepatitis. In the infectious disease arena, the late breaking trials in anti-retroviral disease are discussed, as well as the new trends regarding antibiotic resistance. This review approaches also the role of leukotriene modifiers in the treatment of asthma and discusses the benefit of using methylprednisolone in patients with adult respiratory distress syndrome, among many other advances in internal medicine.

No abstract